|
|
| |
|
10:00 |
Tour of laboratories |
| |
|
10:30 |
Breakfast |
| |
|
11:00 |
Overview (Vincent Mutel, Chief Executive Officer) |
| |
|
| |
|
11:30 |
Allostery Platform: Chemistry (Jean-Philippe Rocher, Head of Core Chemistry) |
| |
|
| |
|
12:00 |
Allostery Platform: Biology (Robert Lütjens, Head of Core Biology) |
| |
|
| |
|
12:30 |
Inflammation Business Unit (Laurent Galibert, Head of Inflammation Unit) |
| |
|
| |
|
13:00 |
Lunch |
| |
|
13:30 |
Metabolic Disease Business Unit (Vincent Mutel, Head of Metabolic Disorders) |
| |
|
| |
|
14:00 |
CNS Business Unit (Emmanuel Le Poul, Head of CNS Unit) |
| |
|
| |
|
14:30 |
Non-clinical Development (Sonia Poli, Head of Non-Clin Dvp) |
| |
|
| |
|
15:00 |
Clinical Development (Charlotte Keywood, Chief Medical Officer) |
| |
|
| |
|
15:30 |
Conclusion (Vincent Mutel, Chief Executive Officer) |
| |
|
| |
|
15:45 |
Tea / Tour of the laboratories |
